Nicole R. Luke-Marshall PhD
Nicole R. Luke-Marshall
PhD
M.S. Program Director; Education & Instructional Support
Department of Microbiology and Immunology
Jacobs School of Medicine & Biomedical Sciences
Specialty/Research Focus
Bacterial Pathogenesis; Infectious Disease; Microbial Pathogenesis; Microbiology
Professional Summary:
M. S. Program Director
Education and Training:
- PhD, Bacterial Pathogenesis, University at Buffalo (2000)
Journal Articles:
- Luke-Marshall NR, Hansen LA, Shafirstein G, Campagnari AA. (2020) Antimicrobial Photodynamic Therapy with Chlorin e6 Is Bactericidal against Biofilms of the Primary Human Otopathogens. mSphere (Jul), 5(4). doi:10.1128/mSphere.00492-20
- Ren D, Almudevar AL, Murphy TF, Lafontaine ER, Campagnari AA, Luke-Marshall N, Pichichero ME. (2019) Serum antibody response to Moraxella catarrhalis proteins in stringently defined otitis prone children. Vaccine (Jul), 37(32): 4637-4645. doi:10.1016/j.vaccine.2017.07.027
- Canty MK, Hansen LA, Tobias M, Spencer S, Henry T, Luke-Marshall NR, Campagnari AA, Ehrensberger MT. (2019) Antibiotics Enhance Prevention and Eradication Efficacy of Cathodic-Voltage-Controlled Electrical Stimulation against Titanium-Associated Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Biofilms. mSphere (May), 4(3). doi:10.1128/mSphere.00178-19
- Scott EJ, Luke-Marshall NR, Campagnari AA, Dyer DW. (2019) Draft Genome Sequence of Pediatric Otitis Media Isolate Streptococcus pneumoniae Strain EF3030, Which Forms In Vitro Biofilms That Closely Mimic In Vivo Biofilms. Microbiology resource announcements (Jan), 8(2). doi:10.1128/MRA.01114-18
- Brooks EK, Ahn R, Tobias ME, Hansen LA, Luke-Marshall NR, Wild L, Campagnari AA, Ehrensberger MT. (2018) Magnesium alloy AZ91 exhibits antimicrobial properties in vitro but not in vivo. Journal of biomedical materials research. Part B, Applied biomaterials (Jan), 106(1): 221-227.
- Reddinger RM, Luke-Marshall NR, Sauberan SL, Hakansson AP, Campagnari AA. (2018) Streptococcus pneumoniae Modulates Staphylococcus aureus Biofilm Dispersion and the Transition from Colonization to Invasive Disease. mBio (Jan), 9(1). doi:10.1128/mBio.02089-17
- Canty M, Luke-Marshall N, Campagnari A, Ehrensberger M. (2017) Cathodic voltage-controlled electrical stimulation of titanium for prevention of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii biofilm infections. Acta biomaterialia (Jan), 48: 451-460.
- Reddinger RM, Luke-Marshall NR, Hakansson AP, Campagnari AA. (2016) Host Physiologic Changes Induced by Influenza A Virus Lead to Staphylococcus aureus Biofilm Dispersion and Transition from Asymptomatic Colonization to Invasive Disease. mBio (Aug), 7(4). doi:10.1128/mBio.01235-16
- Nodzo SR, Tobias M, Ahn R, Hansen L, Luke-Marshall NR, Howard C, Wild L, Campagnari AA, Ehrensberger MT. (2016) Cathodic Voltage-controlled Electrical Stimulation Plus Prolonged Vancomycin Reduce Bacterial Burden of a Titanium Implant-associated Infection in a Rodent Model. Clinical orthopaedics and related research (Jul), 474(7): 1668-75. doi:10.1007/s11999-016-4705-7
- Ren D, Almudevar AL, Murphy TF, Lafontaine ER, Campagnari AA, Luke-Marshall N, Casey JR, Pichichero ME. (2015) Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in children. Vaccine (Oct), 33(43): 5809-5814. doi:10.1016/j.vaccine.2015.09.023
- Nodzo S, Tobias M, Hansen L, Luke-Marshall NR, Cole R, Wild L, Campagnari AA, Ehrensberger MT. (2015) Cathodic Electrical Stimulation Combined With Vancomycin Enhances Treatment of Methicillin-resistant Staphylococcus aureus Implant-associated Infections. Clinical orthopaedics and related research (Sep), 473(9): 2856-64. doi:10.1007/s11999-015-4280-3
- Ehrensberger MT, Tobias ME, Nodzo SR, Hansen LA, Luke-Marshall NR, Cole RF, Wild LM, Campagnari AA. (2015) Cathodic voltage-controlled electrical stimulation of titanium implants as treatment for methicillin-resistant Staphylococcus aureus periprosthetic infections. Biomaterials (Feb), 41: 97-105.
- Luke-Marshall NR, Mang TS, Hansen LA, Campagnari AA. (2014) Moraxella catarrhalis is susceptible to antimicrobial photodynamic therapy with Photofrin. Lasers in surgery and medicine (Nov), 46(9): 712-7.
- Luke-Marshall NR, Edwards KJ, Sauberan S, St Michael F, Vinogradov EV, Cox AD, Campagnari AA. (2013) Characterization of a trifunctional glucosyltransferase essential for Moraxella catarrhalis lipooligosaccharide assembly. Glycobiology (Aug), 23(8): 1013-21. doi:10.1093/glycob/cwt042
- Russo TA, Beanan JM, Olson R, MacDonald U, Cox AD, St Michael F, Vinogradov EV, Spellberg B, Luke-Marshall NR, Campagnari AA. (2013) The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization. Infection and immunity (Mar), 81(3): 915-22. doi:10.1128/IAI.01184-12
- Luke-Marshall NR, Sauberan SL, Campagnari AA. (2011) Comparative analyses of the Moraxella catarrhalis type-IV pilus structural subunit PilA. Gene (May), 477(1-2): 19-23.
- Russo TA, Luke NR, Beanan JM, Olson R, Sauberan SL, MacDonald U, Schultz LW, Umland TC, Campagnari AA. (2010) The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infection and immunity (Sep), 78(9): 3993-4000. doi:10.1128/IAI.00366-10
- Luke NR, Sauberan SL, Russo TA, Beanan JM, Olson R, Loehfelm TW, Cox AD, St Michael F, Vinogradov EV, Campagnari AA. (2010) Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis. Infection and immunity (May), 78(5): 2017-23. doi:10.1128/IAI.00016-10
- Russo TA, MacDonald U, Beanan JM, Olson R, MacDonald IJ, Sauberan SL, Luke NR, Schultz LW, Umland TC. (2009) Penicillin-binding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo. The Journal of infectious diseases (Feb), 199(4): 513-21.
- Russo TA, Beanan JM, Olson R, MacDonald U, Luke NR, Gill SR, Campagnari AA. (2008) Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology. Infection and immunity (Aug), 76(8): 3577-86. doi:10.1128/IAI.00269-08
- Loehfelm TW, Luke NR, Campagnari AA. (2008) Identification and characterization of an Acinetobacter baumannii biofilm-associated protein. Journal of bacteriology (Feb), 190(3): 1036-44. doi:10.1128/JB.01416-07
- Luke NR, Jurcisek JA, Bakaletz LO, Campagnari AA. (2007) Contribution of Moraxella catarrhalis type IV pili to nasopharyngeal colonization and biofilm formation. Infection and immunity (Dec), 75(12): 5559-64. doi:10.1128/IAI.00946-07
- Plamondon P, Luke NR, Campagnari AA. (2007) Identification of a novel two-partner secretion locus in Moraxella catarrhalis. Infection and immunity (Jun), 75(6): 2929-36. doi:10.1128/IAI.00396-07
- Janowicz D, Luke NR, Fortney KR, Katz BP, Campagnari AA, Spinola SM. (2006) Expression of OmpP2A and OmpP2B is not required for pustule formation by Haemophilus ducreyi in human volunteers. Microbial pathogenesis (Mar), 40(3): 110-5.
- Furano K, Luke NR, Howlett AJ, Campagnari AA. (2005) Identification of a conserved Moraxella catarrhalis haemoglobin-utilization protein, MhuA. Microbiology (Reading, England) (Apr), 151(Pt 4): 1151-1158.
- Luke NR, Howlett AJ, Shao J, Campagnari AA. (2004) Expression of type IV pili by Moraxella catarrhalis is essential for natural competence and is affected by iron limitation. Infection and immunity (Nov), 72(11): 6262-70. doi:10.1128/IAI.72.11.6262-6270.2004
- Luke NR, Allen S, Gibson BW, Campagnari AA. (2003) Identification of a 3-deoxy-D-manno-octulosonic acid biosynthetic operon in Moraxella catarrhalis and analysis of a KdsA-deficient isogenic mutant. Infection and immunity (Nov), 71(11): 6426-34. doi:10.1128/IAI.71.11.6426-6434.2003
- Luke NR, Karalus RJ, Campagnari AA. (2002) Inactivation of the Moraxella catarrhalis superoxide dismutase SodA induces constitutive expression of iron-repressible outer membrane proteins. Infection and immunity (Apr), 70(4): 1889-95. doi:10.1128/IAI.70.4.1889-1895.2002
- Luke NR, Campagnari AA. (1999) Construction and characterization of Moraxella catarrhalis mutants defective in expression of transferrin receptors. Infection and immunity (Nov), 67(11): 5815-9. doi:10.1128/iai.67.11.5815-5819.1999
- Luke NR, Russo TA, Luther N, Campagnari AA. (1999) Use of an isogenic mutant constructed in Moraxella catarrhalis To identify a protective epitope of outer membrane protein B1 defined by monoclonal antibody 11C6. Infection and immunity (Feb), 67(2): 681-7. doi:10.1128/iai.67.2.681-687.1999